BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shafabakhsh R, Reiter RJ, Mirzaei H, Teymoordash SN, Asemi Z. Melatonin: A new inhibitor agent for cervical cancer treatment. J Cell Physiol 2019;234:21670-82. [PMID: 31131897 DOI: 10.1002/jcp.28865] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen Y, Dou Z, Chen X, Zhao D, Che T, Su W, Qu T, Zhang T, Xu C, Lei H, Li Q, Zhang H, Di C. Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells. J Cancer Res Clin Oncol 2022. [PMID: 35896897 DOI: 10.1007/s00432-022-04170-3] [Reference Citation Analysis]
2 Vaghari-Tabari M, Hassanpour P, Sadeghsoltani F, Malakoti F, Alemi F, Qujeq D, Asemi Z, Yousefi B. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer. Cell Mol Biol Lett 2022;27:49. [PMID: 35715750 DOI: 10.1186/s11658-022-00348-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Maleki Dana P, Sadoughi F, Mirzaei H, Asemi Z, Yousefi B. DNA damage response and repair in the development and treatment of brain tumors. European Journal of Pharmacology 2022;924:174957. [DOI: 10.1016/j.ejphar.2022.174957] [Reference Citation Analysis]
4 Almoshari Y. Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review. Pharmaceutics 2022;14:600. [DOI: 10.3390/pharmaceutics14030600] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pratap PD, Raza ST, Zaidi G, Kunwar S, Ahmad S, Charles MR, Eba A, Rajput M. Genetic Variants in Interleukin-10 Gene Association with Susceptibility and Cervical Cancer Development: A Case Control Study. Glob Med Genet. [DOI: 10.1055/s-0042-1743262] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Salami R, Salami M, Mafi A, Vakili O, Asemi Z. Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms. Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-021-00809-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
7 Nikolaev G, Robeva R, Konakchieva R. Membrane Melatonin Receptors Activated Cell Signaling in Physiology and Disease. Int J Mol Sci 2021;23:471. [PMID: 35008896 DOI: 10.3390/ijms23010471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zivarpour P, Hallajzadeh J, Asemi Z, Sadoughi F, Sharifi M. Chitosan as possible inhibitory agents and delivery systems in leukemia. Cancer Cell Int 2021;21:544. [PMID: 34663339 DOI: 10.1186/s12935-021-02243-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Pourmohammad P, Maroufi NF, Rashidi M, Vahedian V, Pouremamali F, Faridvand Y, Ghaffari-Novin M, Isazadeh A, Hajazimian S, Nejabati HR, Nouri M. Potential Therapeutic Effects of Melatonin Mediate via miRNAs in Cancer. Biochem Genet 2021. [PMID: 34181134 DOI: 10.1007/s10528-021-10104-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ye G, Wang L, Yang K, Wang C. Fucoxanthin may inhibit cervical cancer cell proliferation via downregulation of HIST1H3D. J Int Med Res 2020;48:300060520964011. [PMID: 33086884 DOI: 10.1177/0300060520964011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Ezzati M, Velaei K, Kheirjou R. Melatonin and its mechanism of action in the female reproductive system and related malignancies. Mol Cell Biochem 2021;476:3177-90. [PMID: 33864572 DOI: 10.1007/s11010-021-04151-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
12 Bai L, Ma Y, Wang X, Feng Q, Zhang Z, Wang S, Zhang H, Lu X, Xu Y, Zhao E, Cui H. Polydatin Inhibits Cell Viability, Migration, and Invasion Through Suppressing the c-Myc Expression in Human Cervical Cancer. Front Cell Dev Biol 2021;9:587218. [PMID: 33912552 DOI: 10.3389/fcell.2021.587218] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
13 Bai Y, Yang L, Zhang C, Yang Y. Studies on the Mechanism of Alloimperatorin on the Proliferation and Apoptosis of HeLa Cells. J Oncol 2021;2021:6617312. [PMID: 33897778 DOI: 10.1155/2021/6617312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Li L, Peng Q, Gong M, Ling L, Xu Y, Liu Q. Using lncRNA Sequencing to Reveal a Putative lncRNA-mRNA Correlation Network and the Potential Role of PCBP1-AS1 in the Pathogenesis of Cervical Cancer. Front Oncol 2021;11:634732. [PMID: 33833992 DOI: 10.3389/fonc.2021.634732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Mao Y, Chen R, Xia M, Guo P, Zeng F, Huang J, He M. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma. Future Oncol 2021;17:2365-80. [PMID: 33724869 DOI: 10.2217/fon-2020-1153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Tan X, Li K, Zhang J, Wang W, Wu B, Wu J, Li X, Huang X. Automatic model for cervical cancer screening based on convolutional neural network: a retrospective, multicohort, multicenter study. Cancer Cell Int 2021;21:35. [PMID: 33413391 DOI: 10.1186/s12935-020-01742-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
17 Wang Y, Tao B, Li J, Mao X, He W, Chen Q. Melatonin Inhibits the Progression of Oral Squamous Cell Carcinoma via Inducing miR-25-5p Expression by Directly Targeting NEDD9. Front Oncol 2020;10:543591. [PMID: 33344223 DOI: 10.3389/fonc.2020.543591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
18 Rajput M, Kumar M, Kumari M, Bhattacharjee A, Awasthi AA. Identification of key genes and construction of regulatory network for the progression of cervical cancer. Gene Reports 2020;21:100965. [DOI: 10.1016/j.genrep.2020.100965] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Datta A, Tuz Zahora F, Abdul Aziz M, Sarowar Uddin M, Ferdous M, Shalahuddin Millat M, Shahid Sarwar M, Abdul Barek M, Jafrin S, Nahar S, Safiqul Islam M. Association study of IL10 gene polymorphisms (rs1800872 and rs1800896) with cervical cancer in the Bangladeshi women. International Immunopharmacology 2020;89:107091. [DOI: 10.1016/j.intimp.2020.107091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Feng D, Yan K, Liang H, Liang J, Wang W, Yu H, Zhou Y, Zhao W, Dong Z, Ling B. CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2. Neoplasia 2021;23:1-11. [PMID: 33190089 DOI: 10.1016/j.neo.2020.10.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Malik R, Fazal S, Kamal MA. Computational Analysis of Dynamical Fluctuations of Oncoprotein E7 (HPV 16) for the Hot Spot Residue Identification Using Elastic Network Model. LDDD 2020;17:1393-1400. [DOI: 10.2174/1570180817999200606225735] [Reference Citation Analysis]
22 Cavalcanti A, Murphy DG, Dasgupta P. Nanorobot for Cancer Biomarker Instrumentation. 2020 IEEE 15th International Conference on Nano/Micro Engineered and Molecular System (NEMS) 2020. [DOI: 10.1109/nems50311.2020.9265632] [Reference Citation Analysis]
23 Yang S, Jiang Y, Ren X, Feng D, Zhang L, He D, Hong S, Jin L, Zhang F, Lu S. FOXA1-induced circOSBPL10 potentiates cervical cancer cell proliferation and migration through miR-1179/UBE2Q1 axis. Cancer Cell Int 2020;20:389. [PMID: 32831649 DOI: 10.1186/s12935-020-01360-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
24 Socaciu AI, Ionuţ R, Socaciu MA, Ungur AP, Bârsan M, Chiorean A, Socaciu C, Râjnoveanu AG. Melatonin, an ubiquitous metabolic regulator: functions, mechanisms and effects on circadian disruption and degenerative diseases. Rev Endocr Metab Disord 2020;21:465-78. [PMID: 32691289 DOI: 10.1007/s11154-020-09570-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 11.5] [Reference Citation Analysis]
25 Kvietkauskas M, Zitkute V, Leber B, Strupas K, Stiegler P, Schemmer P. The role of melatonin in colorectal cancer treatment: a comprehensive review. Ther Adv Med Oncol 2020;12:1758835920931714. [PMID: 32733605 DOI: 10.1177/1758835920931714] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
26 Gu Q, Hou W, Liu H, Shi L, Zhu Z, Ye W, Ni X. NUP210 and MicroRNA-22 Modulate Fas to Elicit HeLa Cell Cycle Arrest. Yonsei Med J 2020;61:371-81. [PMID: 32390360 DOI: 10.3349/ymj.2020.61.5.371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 El-Missiry MA, El-Missiry ZMA, Othman AI. Melatonin is a potential adjuvant to improve clinical outcomes in individuals with obesity and diabetes with coexistence of Covid-19. Eur J Pharmacol 2020;882:173329. [PMID: 32615182 DOI: 10.1016/j.ejphar.2020.173329] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 18.0] [Reference Citation Analysis]
28 Liu N, Ma M, Qu N, Wang R, Chen H, Hu F, Gao S, Shan F. Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo. Int Immunopharmacol 2020;86:106718. [PMID: 32585612 DOI: 10.1016/j.intimp.2020.106718] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
29 Lin SL, Wang M, Cao QQ, Li Q. Chromatin modified protein 4C (CHMP4C) facilitates the malignant development of cervical cancer cells. FEBS Open Bio 2020;10:1295-303. [PMID: 32406588 DOI: 10.1002/2211-5463.12880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
30 Ashrafizadeh M, Zarrabi A, Samarghandian S, Najafi M. PTEN: What we know of the function and regulation of this onco-suppressor factor in bladder cancer? Eur J Pharmacol 2020;881:173226. [PMID: 32485246 DOI: 10.1016/j.ejphar.2020.173226] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
31 Lin Z, Lin Y, Shen J, Jiang M, Hou Y. Flavonoids in Ageratum conyzoides L. Exert Potent Antitumor Effects on Human Cervical Adenocarcinoma HeLa Cells In Vitro and In Vivo. Biomed Res Int 2020;2020:2696350. [PMID: 32461974 DOI: 10.1155/2020/2696350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
32 Tang X, Liu S, Ding Y, Guo C, Guo J, Hua K, Qiu J. Serum Circular FoxO3a Serves as a Novel Prognostic Biomarker in Squamous Cervical Cancer. Cancer Manag Res 2020;12:2531-40. [PMID: 32308490 DOI: 10.2147/CMAR.S243329] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
33 Xia C, He Z, Cai Y. Quantitative proteomics analysis of differentially expressed proteins induced by astragaloside IV in cervical cancer cell invasion. Cell Mol Biol Lett 2020;25:25. [PMID: 32265995 DOI: 10.1186/s11658-020-00218-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
34 Chaichian S, Moazzami B, Sadoughi F, Haddad Kashani H, Zaroudi M, Asemi Z. Functional activities of beta-glucans in the prevention or treatment of cervical cancer. J Ovarian Res 2020;13:24. [PMID: 32138756 DOI: 10.1186/s13048-020-00626-7] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
35 Liu F, Wen C. LINC01410 Knockdown Suppresses Cervical Cancer Growth and Invasion via Targeting miR-2467-3p/VOPP1 Axis. Cancer Manag Res 2020;12:855-61. [PMID: 32104067 DOI: 10.2147/CMAR.S236832] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
36 Xia C, Yang F, He Z, Cai Y. iTRAQ-based quantitative proteomic analysis of the inhibition of cervical cancer cell invasion and migration by metformin. Biomed Pharmacother 2020;123:109762. [PMID: 31864213 DOI: 10.1016/j.biopha.2019.109762] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
37 Neamati F, Asemi Z. The effects of melatonin on signaling pathways and molecules involved in glioma. Fundam Clin Pharmacol 2020;34:192-9. [PMID: 31808968 DOI: 10.1111/fcp.12526] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
38 Shafabakhsh R, Mirzaei H, Asemi Z. Melatonin: A promising agent targeting leukemia. J Cell Biochem 2020;121:2730-8. [PMID: 31713261 DOI: 10.1002/jcb.29495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
39 Banerjee S, Karunagaran D. An integrated approach for mining precise RNA-based cervical cancer staging biomarkers. Gene 2019;712:143961. [PMID: 31279709 DOI: 10.1016/j.gene.2019.143961] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
40 Jo S, Department of Physiology, Institute of Bioscience and Biotechnology, BK21 Plus Graduate Program, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea, Lee S, Kim K, Choi S. Melatonin inhibits nicotinic acetylcholine receptor functions in bovine chromaffin cells. Intern J Oral Biol 2019;44:50-54. [DOI: 10.11620/ijob.2019.44.2.50] [Reference Citation Analysis]
41 Shirmohammadi M, Soleimanjahi H, Kianmehr Z, Karimi H, Kaboudanian Ardestani S. Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines. Iran J Basic Med Sci 2021;24:92-7. [PMID: 33643576 DOI: 10.22038/ijbms.2020.51043.11608] [Reference Citation Analysis]